Delaware 2023 2023-2024 Regular Session

Delaware House Bill HCR95 Draft / Bill

                    SPONSOR:      Rep. Neal & Rep. Dorsey Walker & Sen. Hoffner       Reps. Baumbach, Osienski, Morrison, K. Johnson, Romer, Parker Selby, Hensley, Michael Smith, Hilovsky, Bush, Phillips, Ramone, Yearick; Sens. Sokola, Mantzavinos, Hansen, Gay, Huxtable, Pettyjohn, Hocker, Wilson, Lawson           HOUSE OF REPRESENTATIVES   152nd GENERAL ASSEMBLY       HOUSE CONCURRENT RESOLUTION NO. 95       RECOGNIZING THE MONTH OF MARCH AS MULTIPLE SCLEROSIS MONTH IN DELAWARE.      

     

     SPONSOR:      Rep. Neal & Rep. Dorsey Walker & Sen. Hoffner       Reps. Baumbach, Osienski, Morrison, K. Johnson, Romer, Parker Selby, Hensley, Michael Smith, Hilovsky, Bush, Phillips, Ramone, Yearick; Sens. Sokola, Mantzavinos, Hansen, Gay, Huxtable, Pettyjohn, Hocker, Wilson, Lawson     

SPONSOR: Rep. Neal & Rep. Dorsey Walker & Sen. Hoffner
Reps. Baumbach, Osienski, Morrison, K. Johnson, Romer, Parker Selby, Hensley, Michael Smith, Hilovsky, Bush, Phillips, Ramone, Yearick; Sens. Sokola, Mantzavinos, Hansen, Gay, Huxtable, Pettyjohn, Hocker, Wilson, Lawson

 SPONSOR:  

 Rep. Neal & Rep. Dorsey Walker & Sen. Hoffner 

 Reps. Baumbach, Osienski, Morrison, K. Johnson, Romer, Parker Selby, Hensley, Michael Smith, Hilovsky, Bush, Phillips, Ramone, Yearick; Sens. Sokola, Mantzavinos, Hansen, Gay, Huxtable, Pettyjohn, Hocker, Wilson, Lawson 

   

 HOUSE OF REPRESENTATIVES 

 152nd GENERAL ASSEMBLY 

   

 HOUSE CONCURRENT RESOLUTION NO. 95 

   

 RECOGNIZING THE MONTH OF MARCH AS MULTIPLE SCLEROSIS MONTH IN DELAWARE. 

   

  WHEREAS, Multiple Sclerosis (referred to in this resolution as MS) is a chronic and unpredictable disease affecting the nervous system; and   WHEREAS, symptoms of MS range from numbness and tingling in the extremities to blindness, paralysis, and cognitive dysfunction; and   WHEREAS, the progress, severity, and specific symptoms of MS in any one person cannot yet be predicted; and   WHEREAS, there is no laboratory test available that can definitively diagnose MS; and   WHEREAS, most people with MS experience their first symptoms and are diagnosed between the ages of 15 and 50, although individuals of any age may be diagnosed; and   WHEREAS, an estimated 2.3 million people worldwide are affected by MS; and   WHEREAS, female individuals have a higher MS burden than male individuals; and   WHEREAS, while MS is not directly inherited, studies show that there are genetic and, probably, environmental factors that make certain individuals, more predisposed; and   WHEREAS, the exact cause of MS is still unknown and there is no cure; and   WHEREAS, education is a continuing need among everyone involved with MS, from medical professionals to patients, family, and friends; and   WHEREAS, The Multiple Sclerosis Association of America recognizes March as Multiple Sclerosis Awareness Month; and   WHEREAS, the goals of Multiple Sclerosis Awareness Month are to acknowledge those who have been diagnosed with MS, invite people to join the movement to end MS, encourage everyone to educate themselves on the discourse and research surrounding MS, and to recognize those who have dedicated their time and talent to help promote MS research and programs.   NOW, THEREFORE:    BE IT RESOLVED by the House of Representatives of the 152nd General Assembly of the State of Delaware, the Senate concurring therein, that March 2024 is hereby designated as Multiple Sclerosis Month, and the State Legislature calls upon Delawareans to observe this month by learning about Multiple Sclerosis and supporting individuals who have been medically diagnosed with MS.      

 WHEREAS, Multiple Sclerosis (referred to in this resolution as MS) is a chronic and unpredictable disease affecting the nervous system; and 

 WHEREAS, symptoms of MS range from numbness and tingling in the extremities to blindness, paralysis, and cognitive dysfunction; and 

 WHEREAS, the progress, severity, and specific symptoms of MS in any one person cannot yet be predicted; and 

 WHEREAS, there is no laboratory test available that can definitively diagnose MS; and 

 WHEREAS, most people with MS experience their first symptoms and are diagnosed between the ages of 15 and 50, although individuals of any age may be diagnosed; and 

 WHEREAS, an estimated 2.3 million people worldwide are affected by MS; and 

 WHEREAS, female individuals have a higher MS burden than male individuals; and 

 WHEREAS, while MS is not directly inherited, studies show that there are genetic and, probably, environmental factors that make certain individuals, more predisposed; and 

 WHEREAS, the exact cause of MS is still unknown and there is no cure; and 

 WHEREAS, education is a continuing need among everyone involved with MS, from medical professionals to patients, family, and friends; and 

 WHEREAS, The Multiple Sclerosis Association of America recognizes March as Multiple Sclerosis Awareness Month; and 

 WHEREAS, the goals of Multiple Sclerosis Awareness Month are to acknowledge those who have been diagnosed with MS, invite people to join the movement to end MS, encourage everyone to educate themselves on the discourse and research surrounding MS, and to recognize those who have dedicated their time and talent to help promote MS research and programs. 

 NOW, THEREFORE:  

 BE IT RESOLVED by the House of Representatives of the 152nd General Assembly of the State of Delaware, the Senate concurring therein, that March 2024 is hereby designated as Multiple Sclerosis Month, and the State Legislature calls upon Delawareans to observe this month by learning about Multiple Sclerosis and supporting individuals who have been medically diagnosed with MS. 

   

  SYNOPSIS   This House Concurrent Resolution recognizes the month of March 2024 as Multiple Sclerosis Month in the State of Delaware.      

 SYNOPSIS 

 This House Concurrent Resolution recognizes the month of March 2024 as Multiple Sclerosis Month in the State of Delaware.